OnKure Therapeutics (OKUR) Total Non-Current Liabilities (2021 - 2026)
OnKure Therapeutics' (OKUR) quarterly Total Non-Current Liabilities came in at $14.3 million in Q1 2026, up 55.85% YoY from $9.2 million in Q1 2025, and up 142.0% on a QoQ basis from $5.9 million in Q4 2025.
OnKure Therapeutics (OKUR) Total Non-Current Liabilities (2021 - 2026) Analysis & Trends
OnKure Therapeutics (OKUR) has 3 years of Total Non-Current Liabilities data on file, last reported at $14.3 million in Q1 2026.
- Quarterly Total Non-Current Liabilities rose 55.85% year-over-year to $14.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.3 million (up 55.85% YoY) and the FY2025 annual result came in at $5.9 million, changed N/A from the prior year.
- Total Non-Current Liabilities climbed to $14.3 million in Q1 2026, from $5.9 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $14.3 million in Q1 2026 to a low of $5.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 5.92 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 7.74 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 40.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 3.92 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.88 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 4.20 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.17 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 9.32 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 724.15 Mn |
| 10 | OnKure Therapeutics | 196.98 Mn | 20.60 Mn | - | 7.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.23 Mn |
| Mar 31, 2026 | 14.33 Mn |
| Dec 31, 2025 | 5.92 Mn |
| Sep 30, 2025 | 6.37 Mn |
| Jun 30, 2025 | 7.86 Mn |
| Mar 31, 2025 | 9.19 Mn |
| Dec 31, 2021 | 6.65 Mn |